- Markets
- Chemicals
- CAMLINFINE
CAMLINFINE
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
-
Share Price
-
Financials
-
Revenue mix
-
Shareholdings
-
Peers
-
Forensics
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
This data is currently unavailable for this company.
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
| (In Cr.) |
|---|
| (In Cr.) | ||||
|---|---|---|---|---|
|
This data is currently unavailable for this company. |
| (In %) |
|---|
| (In Cr.) |
|---|
| Financial Year (In Cr.) |
|---|
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Recent events
-
News
-
Corporate Actions
Camlin Fine Sciences To Acquire Majority Stake In Vinpai
Feb 25 (Reuters) - Camlin Fine Sciences Ltd CAMF.NS:
CAMLIN FINE SCIENCES LTD - TO ACQUIRE MAJORITY STAKE IN VINPAI
CAMLIN FINE SCIENCES LTD - ACQUISITION PAID IN NEWLY ISSUED CFSL SHARES
CAMLIN FINE SCIENCES LTD - VINPAI SHARE PRICE SET AT €3.60
Source text: ID:nNSE5rCdrw
Further company coverage: CAMF.NS
(([email protected];;))
Feb 25 (Reuters) - Camlin Fine Sciences Ltd CAMF.NS:
CAMLIN FINE SCIENCES LTD - TO ACQUIRE MAJORITY STAKE IN VINPAI
CAMLIN FINE SCIENCES LTD - ACQUISITION PAID IN NEWLY ISSUED CFSL SHARES
CAMLIN FINE SCIENCES LTD - VINPAI SHARE PRICE SET AT €3.60
Source text: ID:nNSE5rCdrw
Further company coverage: CAMF.NS
(([email protected];;))
Camlin Fine Sciences Dec-Quarter Consol Net Loss 41.4 Million Rupees
Feb 14 (Reuters) - Camlin Fine Sciences Ltd CAMF.NS:
CAMLIN FINE SCIENCES DEC-QUARTER CONSOL NET LOSS 41.4 MILLION RUPEES
CAMLIN FINE SCIENCES DEC-QUARTER CONSOL REVENUE FROM OPERATIONS 4.33 BILLION RUPEES
Source text: [ID:]
Further company coverage: CAMF.NS
(([email protected];))
Feb 14 (Reuters) - Camlin Fine Sciences Ltd CAMF.NS:
CAMLIN FINE SCIENCES DEC-QUARTER CONSOL NET LOSS 41.4 MILLION RUPEES
CAMLIN FINE SCIENCES DEC-QUARTER CONSOL REVENUE FROM OPERATIONS 4.33 BILLION RUPEES
Source text: [ID:]
Further company coverage: CAMF.NS
(([email protected];))
Camlin Fine Sciences Gets Order With IGST Demand
Jan 14 (Reuters) - Camlin Fine Sciences Ltd CAMF.NS:
GETS ORDER WITH IGST DEMAND OF 33.3 MILLION RUPEES
GETS TAX ORDER WITH PENALTY OF 33.3 MILLION RUPEES
Source text: ID:nBSE7ZS87f
Further company coverage: CAMF.NS
(([email protected];;))
Jan 14 (Reuters) - Camlin Fine Sciences Ltd CAMF.NS:
GETS ORDER WITH IGST DEMAND OF 33.3 MILLION RUPEES
GETS TAX ORDER WITH PENALTY OF 33.3 MILLION RUPEES
Source text: ID:nBSE7ZS87f
Further company coverage: CAMF.NS
(([email protected];;))
Camlin Fine Sciences Says Rights Issue Price 110 Rupees Per Rights Equity Share
Jan 2 (Reuters) - Camlin Fine Sciences Ltd CAMF.NS:
CAMLIN FINE SCIENCES - RIGHTS ISSUE PRICE 110 RUPEES PER RIGHTS EQUITY SHARE
Source text: [ID:]
Further company coverage: CAMF.NS
(([email protected];))
Jan 2 (Reuters) - Camlin Fine Sciences Ltd CAMF.NS:
CAMLIN FINE SCIENCES - RIGHTS ISSUE PRICE 110 RUPEES PER RIGHTS EQUITY SHARE
Source text: [ID:]
Further company coverage: CAMF.NS
(([email protected];))
Camlin Fine Sciences ReviseS Quantum Of Rights Issue To Amount Not Exceeding 2.25 Bln Rupees
Nov 22 (Reuters) - Camlin Fine Sciences Ltd CAMF.NS:
REVISED QUANTUM OF RIGHTS ISSUE TO AMOUNT NOT EXCEEDING 2.25 BILLION RUPEES
APROVED FUND RAISING VIA NCDS AGGREGATING TO 1 BILLION RUPEES
Source text: ID:nBSE51BGcd
Further company coverage: CAMF.NS
(([email protected];;))
Nov 22 (Reuters) - Camlin Fine Sciences Ltd CAMF.NS:
REVISED QUANTUM OF RIGHTS ISSUE TO AMOUNT NOT EXCEEDING 2.25 BILLION RUPEES
APROVED FUND RAISING VIA NCDS AGGREGATING TO 1 BILLION RUPEES
Source text: ID:nBSE51BGcd
Further company coverage: CAMF.NS
(([email protected];;))
Camlin Fine Sciences To Consider Revision Of Quantum Of Proposed Rights Issue
Nov 18 (Reuters) - Camlin Fine Sciences Ltd CAMF.NS:
CAMLIN FINE SCIENCES LTD - TO CONSIDER REVISION OF QUANTUM OF PROPOSED RIGHTS ISSUE
CAMLIN FINE SCIENCES LTD - TO CONSIDER ISSUE OF DEBT SECURITIES
Source text: ID:nBSE9zFBJK
Further company coverage: CAMF.NS
(([email protected];;))
Nov 18 (Reuters) - Camlin Fine Sciences Ltd CAMF.NS:
CAMLIN FINE SCIENCES LTD - TO CONSIDER REVISION OF QUANTUM OF PROPOSED RIGHTS ISSUE
CAMLIN FINE SCIENCES LTD - TO CONSIDER ISSUE OF DEBT SECURITIES
Source text: ID:nBSE9zFBJK
Further company coverage: CAMF.NS
(([email protected];;))
Camlin Fine Sciences Says Approved Liquidation Of Subsidiary Cfs Pahang Asia Pte Ltd
Nov 11 (Reuters) - Camlin Fine Sciences Ltd CAMF.NS:
CAMLIN FINE SCIENCES - APPROVED LIQUIDATION OF SUBSIDIARY CFS PAHANG ASIA PTE LTD
Source text: ID:nBSEshQ12
Further company coverage: CAMF.NS
(([email protected];))
Nov 11 (Reuters) - Camlin Fine Sciences Ltd CAMF.NS:
CAMLIN FINE SCIENCES - APPROVED LIQUIDATION OF SUBSIDIARY CFS PAHANG ASIA PTE LTD
Source text: ID:nBSEshQ12
Further company coverage: CAMF.NS
(([email protected];))
Camlin Fine Sciences To Consider Proposal For Raising Of Funds By Way Of Rights Issue
Sept 5 (Reuters) - Camlin Fine Sciences Ltd CAMF.NS:
TO CONSIDER PROPOSAL FOR RAISING OF FUNDS BY WAY OF RIGHTS ISSUE
Source text for Eikon: ID:nBSE4ftTDM
Further company coverage: CAMF.NS
(Reporting by VijayDattaram Malkar)
(([email protected];))
Sept 5 (Reuters) - Camlin Fine Sciences Ltd CAMF.NS:
TO CONSIDER PROPOSAL FOR RAISING OF FUNDS BY WAY OF RIGHTS ISSUE
Source text for Eikon: ID:nBSE4ftTDM
Further company coverage: CAMF.NS
(Reporting by VijayDattaram Malkar)
(([email protected];))
India's Camlin Fine Sciences slips on Q1 loss
** Shares of Camlin Fine Sciences Ltd CAMF.NS drop 6.2%
** Specialty chemicals maker reports Q1 loss vs year-ago profit
** Co says margins are facing pricing headwinds, sluggish global demand and increasing raw material prices
** Over 1.1 mln shares traded as of 2:29 p.m. IST vs 30-day avg of over 1.6 mln
** CAMF last down 6%, extending YTD losses to ~24%
(Reporting by Meenakshi Maidas in Bengaluru)
(([email protected];))
** Shares of Camlin Fine Sciences Ltd CAMF.NS drop 6.2%
** Specialty chemicals maker reports Q1 loss vs year-ago profit
** Co says margins are facing pricing headwinds, sluggish global demand and increasing raw material prices
** Over 1.1 mln shares traded as of 2:29 p.m. IST vs 30-day avg of over 1.6 mln
** CAMF last down 6%, extending YTD losses to ~24%
(Reporting by Meenakshi Maidas in Bengaluru)
(([email protected];))
Camlin Fine Sciences June-Quarter Consol Net Loss At 339.5 Million Rupees
Aug 12 (Reuters) - Camlin Fine Sciences Ltd CAMF.NS:
JUNE-QUARTER CONSOL NET LOSS 339.5 MILLION RUPEES
JUNE-QUARTER CONSOL REVENUE FROM OPERATIONS 3.96 BILLION RUPEES
Further company coverage: CAMF.NS
(([email protected];))
Aug 12 (Reuters) - Camlin Fine Sciences Ltd CAMF.NS:
JUNE-QUARTER CONSOL NET LOSS 339.5 MILLION RUPEES
JUNE-QUARTER CONSOL REVENUE FROM OPERATIONS 3.96 BILLION RUPEES
Further company coverage: CAMF.NS
(([email protected];))
India's Camlin Fine Sciences rises on acquiring Belgium's Vitafor Invest
** Shares of specialty chemicals maker Camlin Fine Sciences CAMF.NS rise as much as 8.9% to 113.29 rupees, highest level in seven weeks
** CAMF on Tuesday said it entered an agreement to acquire 100% stake in Belgium-based animal feed company Vitafor Invest NV and its units
** More than 2.4 mln shares change hands by 10:13 a.m. IST, in the most active trading session since April 5
** Stock eyes sixth consecutive session of gains
** Stock last up 6.5%, cutting YTD losses to 18.5%
(Reporting by Anisha Ajith in Bengaluru)
(([email protected];))
** Shares of specialty chemicals maker Camlin Fine Sciences CAMF.NS rise as much as 8.9% to 113.29 rupees, highest level in seven weeks
** CAMF on Tuesday said it entered an agreement to acquire 100% stake in Belgium-based animal feed company Vitafor Invest NV and its units
** More than 2.4 mln shares change hands by 10:13 a.m. IST, in the most active trading session since April 5
** Stock eyes sixth consecutive session of gains
** Stock last up 6.5%, cutting YTD losses to 18.5%
(Reporting by Anisha Ajith in Bengaluru)
(([email protected];))
Camlin Fine Sciences Says Unit To Acquire Vitafor Invest NV, Belgium And Its Units
June 11 (Reuters) - Camlin Fine Sciences Ltd CAMF.NS:
UNIT ENTERED INTO AN SHARE PURCHASE AGREEMENT TO ACQUIRE 100% STAKE IN VITAFOR INVEST NV, BELGIUM AND ITS UNITS
Further company coverage: CAMF.NS
(([email protected];))
June 11 (Reuters) - Camlin Fine Sciences Ltd CAMF.NS:
UNIT ENTERED INTO AN SHARE PURCHASE AGREEMENT TO ACQUIRE 100% STAKE IN VITAFOR INVEST NV, BELGIUM AND ITS UNITS
Further company coverage: CAMF.NS
(([email protected];))
Camlin Fine Sciences Posted Net Loss For March-Quarter
May 20 (Reuters) - Camlin Fine Sciences Ltd CAMF.NS:
CAMLIN FINE SCIENCES LTD - REAPPOINTS ASHISH S. DANDEKAR AS MANAGING DIRECTOR
CAMLIN FINE SCIENCES MARCH-QUARTER CONSOL NET LOSS 771.4 MILLION RUPEES VERSUS PROFIT 91.6 MILLION RUPEES
CAMLIN FINE SCIENCES LTD - REAPPOINTS NIRMAL V. MOMAYA AS MANAGING DIRECTOR
CAMLIN FINE SCIENCES MARCH-QUARTER CONSOL REVENUE FROM OPERATIONS 4.02 BILLION RUPEES VERSUS 4.27 BILLION RUPEES
Source text for Eikon: [ID:]
Further company coverage: CAMF.NS
(([email protected];))
May 20 (Reuters) - Camlin Fine Sciences Ltd CAMF.NS:
CAMLIN FINE SCIENCES LTD - REAPPOINTS ASHISH S. DANDEKAR AS MANAGING DIRECTOR
CAMLIN FINE SCIENCES MARCH-QUARTER CONSOL NET LOSS 771.4 MILLION RUPEES VERSUS PROFIT 91.6 MILLION RUPEES
CAMLIN FINE SCIENCES LTD - REAPPOINTS NIRMAL V. MOMAYA AS MANAGING DIRECTOR
CAMLIN FINE SCIENCES MARCH-QUARTER CONSOL REVENUE FROM OPERATIONS 4.02 BILLION RUPEES VERSUS 4.27 BILLION RUPEES
Source text for Eikon: [ID:]
Further company coverage: CAMF.NS
(([email protected];))
India's Camlin Fine Sciences Reports Loss For Sept-Qtr
Nov 6 (Reuters) - Camlin Fine Sciences Ltd CAMF.NS:
INDIA'S CAMLIN FINE SCIENCES LTD SEPT-QUARTER CONSOL NET LOSS 193.8 MILLION RUPEES VERSUS PROFIT 130.2 MILLION RUPEES
CAMLIN FINE SCIENCES LTD SEPT-QUARTER CONSOL REVENUE FROM OPERATIONS 4.06 BILLION RUPEES VERSUS 4.83 BILLION RUPEES
Source text for Eikon: ID:nBSE6HZLNh
Further company coverage: CAMF.NS
(([email protected];;))
Nov 6 (Reuters) - Camlin Fine Sciences Ltd CAMF.NS:
INDIA'S CAMLIN FINE SCIENCES LTD SEPT-QUARTER CONSOL NET LOSS 193.8 MILLION RUPEES VERSUS PROFIT 130.2 MILLION RUPEES
CAMLIN FINE SCIENCES LTD SEPT-QUARTER CONSOL REVENUE FROM OPERATIONS 4.06 BILLION RUPEES VERSUS 4.83 BILLION RUPEES
Source text for Eikon: ID:nBSE6HZLNh
Further company coverage: CAMF.NS
(([email protected];;))
Camlin Fine Sciences Says Temporarily Closure Of Diphenol Plant Of Unit In Italy Shall Be Extended
Nov 1 (Reuters) - Camlin Fine Sciences Ltd CAMF.NS:
TEMPORARILY CLOSURE OF DIPHENOL PLANT OF UNIT IN ITALY SHALL BE EXTENDED
Source text for Eikon: [ID:]
Further company coverage: CAMF.NS
(([email protected];))
Nov 1 (Reuters) - Camlin Fine Sciences Ltd CAMF.NS:
TEMPORARILY CLOSURE OF DIPHENOL PLANT OF UNIT IN ITALY SHALL BE EXTENDED
Source text for Eikon: [ID:]
Further company coverage: CAMF.NS
(([email protected];))
Camlin Fine Sciences Says Temporarily Closure Of Unit's Italy Diphenol Plant Extending to October 31, 2023
Sept 15 (Reuters) - Camlin Fine Sciences Ltd CAMF.NS:
CAMLIN FINE SCIENCES LTD - TEMPORARILY CLOSURE OF DIPHENOL PLANT OF UNIT IN ITALY SHALL BE EXTENDING UPTO OCTOBER 31, 2023
CAMLIN FINE SCIENCES LTD - CLOSURE EXTENSION DUE TO CONTINUING ISSUE OF DIFFICULT MACRO‐ECONOMIC SITUATION IN EUROPE
CAMLIN FINE SCIENCES LTD - CLOSURE EXTENSION ALSO DUE TO LOW PRICING, WEAK DEMAND ACROSS INDUSTRY
Source text for Eikon: ID:nBSE7X6wk4
Further company coverage: CAMF.NS
(([email protected];))
Sept 15 (Reuters) - Camlin Fine Sciences Ltd CAMF.NS:
CAMLIN FINE SCIENCES LTD - TEMPORARILY CLOSURE OF DIPHENOL PLANT OF UNIT IN ITALY SHALL BE EXTENDING UPTO OCTOBER 31, 2023
CAMLIN FINE SCIENCES LTD - CLOSURE EXTENSION DUE TO CONTINUING ISSUE OF DIFFICULT MACRO‐ECONOMIC SITUATION IN EUROPE
CAMLIN FINE SCIENCES LTD - CLOSURE EXTENSION ALSO DUE TO LOW PRICING, WEAK DEMAND ACROSS INDUSTRY
Source text for Eikon: ID:nBSE7X6wk4
Further company coverage: CAMF.NS
(([email protected];))
Ackermans & Van Haaren Invests EUR 20 Mln In Camlin Fine Sciences
Repeats to widen distribution
Sept 14 (Reuters) - Ackermans & Van Haaren NV ACKB.BR:
ACKERMANS & VAN HAAREN INVESTS 20 MILLION EUROS IN CAMLIN FINE SCIENCES
HAS ACQUIRED A 6.6% SHAREHOLDING FOR A CONSIDERATION OF 20 MILLION EUROS IN CAMLIN FINE SCIENCES LIMITED
Source text for Eikon: ID:nNDL9VL2r4
Further company coverage: ACKB.BR
(Gdansk Newsroom)
(([email protected]; +48 58 769 66 00;))
Repeats to widen distribution
Sept 14 (Reuters) - Ackermans & Van Haaren NV ACKB.BR:
ACKERMANS & VAN HAAREN INVESTS 20 MILLION EUROS IN CAMLIN FINE SCIENCES
HAS ACQUIRED A 6.6% SHAREHOLDING FOR A CONSIDERATION OF 20 MILLION EUROS IN CAMLIN FINE SCIENCES LIMITED
Source text for Eikon: ID:nNDL9VL2r4
Further company coverage: ACKB.BR
(Gdansk Newsroom)
(([email protected]; +48 58 769 66 00;))
Camlin Fine Sciences Says Temporary Closure Of Cfs Europe SpA Diphenol Plant Situated At Ravenna, Italy
Aug 16 (Reuters) - Camlin Fine Sciences Ltd CAMF.NS:
TEMPORARY CLOSURE OF CFS EUROPE SPA DIPHENOL PLANT SITUATED AT RAVENNA, ITALY
TEMPORARY CLOSURE FROM AUGUST 16, 2023 TO SEPTEMBER 15, 2023
TEMPORARY CLOSURE ON DIFFICULT MACRO‐ECONOMIC SITUATION IN EUROPE COUPLED WITH LOW PRICING AND WEAK DEMAND ACROSS INDUSTRY
Source text for Eikon: ID:nBSE2md43f
Further company coverage: CAMF.NS
(([email protected];;))
Aug 16 (Reuters) - Camlin Fine Sciences Ltd CAMF.NS:
TEMPORARY CLOSURE OF CFS EUROPE SPA DIPHENOL PLANT SITUATED AT RAVENNA, ITALY
TEMPORARY CLOSURE FROM AUGUST 16, 2023 TO SEPTEMBER 15, 2023
TEMPORARY CLOSURE ON DIFFICULT MACRO‐ECONOMIC SITUATION IN EUROPE COUPLED WITH LOW PRICING AND WEAK DEMAND ACROSS INDUSTRY
Source text for Eikon: ID:nBSE2md43f
Further company coverage: CAMF.NS
(([email protected];;))
India's Camlin Fine Sciences June-Qtr Consol Net Profit Rises
Aug 11 (Reuters) - Camlin Fine Sciences Ltd CAMF.NS:
INDIA'S CAMLIN FINE SCIENCES JUNE-QUARTER CONSOL NET PROFIT 155.5 MILLION RUPEES VERSUS PROFIT 58.9 MILLION RUPEES
CAMLIN FINE SCIENCES JUNE-QUARTER CONSOL REVENUE FROM OPERATIONS 4.2 BILLION RUPEES VERSUS 3.84 BILLION RUPEES
Source text for Eikon: ID:nBSE2dWpRS
Further company coverage: CAMF.NS
(([email protected];;))
Aug 11 (Reuters) - Camlin Fine Sciences Ltd CAMF.NS:
INDIA'S CAMLIN FINE SCIENCES JUNE-QUARTER CONSOL NET PROFIT 155.5 MILLION RUPEES VERSUS PROFIT 58.9 MILLION RUPEES
CAMLIN FINE SCIENCES JUNE-QUARTER CONSOL REVENUE FROM OPERATIONS 4.2 BILLION RUPEES VERSUS 3.84 BILLION RUPEES
Source text for Eikon: ID:nBSE2dWpRS
Further company coverage: CAMF.NS
(([email protected];;))
India's Camlin Fine Sciences down on March-quarter profit fall
** Shares of specialty chemicals manufacturer Camlin Fine Sciences Ltd CAMF.NS fall as much as 5.4% to 165.4 rupees, lowest since May 10
** Co hits sharpest intraday pct loss since Sept. 16
** CAMF reports 39.5% fall in consolidated net profit for quarter ended March 31 at 91.6 mln rupees ($1.12 mln)
** About 1.38 mln shares change hands as of 11:49 a.m. IST, vs 2x the 30-day avg
** Stock up 9.21% YTD as of last close
($1 = 81.7800 Indian rupees)
(Reporting by Manvi Pant in Bengaluru)
(([email protected];))
** Shares of specialty chemicals manufacturer Camlin Fine Sciences Ltd CAMF.NS fall as much as 5.4% to 165.4 rupees, lowest since May 10
** Co hits sharpest intraday pct loss since Sept. 16
** CAMF reports 39.5% fall in consolidated net profit for quarter ended March 31 at 91.6 mln rupees ($1.12 mln)
** About 1.38 mln shares change hands as of 11:49 a.m. IST, vs 2x the 30-day avg
** Stock up 9.21% YTD as of last close
($1 = 81.7800 Indian rupees)
(Reporting by Manvi Pant in Bengaluru)
(([email protected];))
India's Camlin Fine Sciences March-Quarter Consol Net Profit Falls
May 22 (Reuters) - Camlin Fine Sciences Ltd CAMF.NS:
MARCH-QUARTER CONSOL NET PROFIT 91.6 MILLION RUPEES VERSUS 151.3 MILLION RUPEES
MARCH-QUARTER CONSOL REVENUE FROM OPERATIONS 4.27 BILLION RUPEES VERSUS 3.89 BILLION RUPEES
Source text for Eikon: [ID:]
Further company coverage: CAMF.NS
(([email protected];))
May 22 (Reuters) - Camlin Fine Sciences Ltd CAMF.NS:
MARCH-QUARTER CONSOL NET PROFIT 91.6 MILLION RUPEES VERSUS 151.3 MILLION RUPEES
MARCH-QUARTER CONSOL REVENUE FROM OPERATIONS 4.27 BILLION RUPEES VERSUS 3.89 BILLION RUPEES
Source text for Eikon: [ID:]
Further company coverage: CAMF.NS
(([email protected];))
Infinity Direct Holdings And Infinity Direct Holdings Sidecar I To Make Open Offer To Acquire 26% Stake In Camlin Fine Sciences
April 17 (Reuters) - Camlin Fine Sciences Ltd CAMF.NS:
INFINITY DIRECT HOLDINGS AND INFINITY DIRECT HOLDINGS SIDECAR I TO MAKE OPEN OFFER TO ACQUIRE 26% STAKE IN CO
OPEN OFFER PRICE AT 160 RUPEES PER SHARE
Source text for Eikon: ID:nBSE5GZKqV
Further company coverage: CAMF.NS
(([email protected];))
April 17 (Reuters) - Camlin Fine Sciences Ltd CAMF.NS:
INFINITY DIRECT HOLDINGS AND INFINITY DIRECT HOLDINGS SIDECAR I TO MAKE OPEN OFFER TO ACQUIRE 26% STAKE IN CO
OPEN OFFER PRICE AT 160 RUPEES PER SHARE
Source text for Eikon: ID:nBSE5GZKqV
Further company coverage: CAMF.NS
(([email protected];))
Events:
Rights
Dividend
Dividend
Split
Dividend
More Small Cap Ideas
See similar 'Small' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
-
Business
-
Financials
-
Share Price
-
Shareholdings
What does Camlin Fine Sciences do?
Camlin Fine Sciences is a reputable manufacturer specializing in traditional antioxidants, aroma ingredients, and performance chemicals, prioritizing quality and customer service to establish a strong presence in the industry.
Who are the competitors of Camlin Fine Sciences?
Camlin Fine Sciences major competitors are Privi Speciality Che, Clean Science, Tanfac Industries, Vishnu Chemicals, Tatva Chintan Pharma, Paushak, Ultramar & Pigments. Market Cap of Camlin Fine Sciences is ₹3,201 Crs. While the median market cap of its peers are ₹2,875 Crs.
Is Camlin Fine Sciences financially stable compared to its competitors?
Camlin Fine Sciences seems to be less financially stable compared to its competitors. Altman Z score of Camlin Fine Sciences is 3.34 and is ranked 8 out of its 8 competitors.
Does Camlin Fine Sciences pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Camlin Fine Sciences latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%
How has Camlin Fine Sciences allocated its funds?
Companies resources are majorly tied in miscellaneous assets
How strong is Camlin Fine Sciences balance sheet?
Balance sheet of Camlin Fine Sciences is strong. But short term working capital might become an issue for this company.
Is the profitablity of Camlin Fine Sciences improving?
No, profit is decreasing. The profit of Camlin Fine Sciences is -₹238.67 Crs for TTM, -₹92.75 Crs for Mar 2024 and ₹52.11 Crs for Mar 2023.
Is the debt of Camlin Fine Sciences increasing or decreasing?
Yes, The debt of Camlin Fine Sciences is increasing. Latest debt of Camlin Fine Sciences is ₹649 Crs as of Sep-24. This is greater than Mar-24 when it was ₹471 Crs.
Is Camlin Fine Sciences stock expensive?
Camlin Fine Sciences is expensive when considering the EV/EBIDTA, however latest PE is < 3 yr avg PE. Latest PE of Camlin Fine Sciences is 0.0, while 3 year average PE is 32.32. Also latest EV/EBITDA of Camlin Fine Sciences is 39.72 while 3yr average is 21.59.
Has the share price of Camlin Fine Sciences grown faster than its competition?
Camlin Fine Sciences has given better returns compared to its competitors. Camlin Fine Sciences has grown at ~10.26% over the last 3yrs while peers have grown at a median rate of -2.36%
Is the promoter bullish about Camlin Fine Sciences?
Promoters seem to be bullish about the company. Latest quarter promoter holding is 49.1% and last quarter promoter holding is 48.02%.
Are mutual funds buying/selling Camlin Fine Sciences?
The mutual fund holding of Camlin Fine Sciences is increasing. The current mutual fund holding in Camlin Fine Sciences is 3.48% while previous quarter holding is 3.38%.